Morehouse School of Medicine
Punit Kaur finished her B.Sc. in 1999 with Botany, Zoology and Chemistry from Punjab University, Chandigarh, India. Then she went for Postgrad (M.Sc.) (1999-2001) in Microbiology from Guru Nanak Dev University, Amritsar, Punjab, India. Later she pursued for Ph.D (2001-2008) on the topic Experimental Medicine and Biotechnology from the Postgraduate Institute of Medical Education and Research, Chandigarh, India
Punit Kaur along with other members of the organization focus on the research and development of heat shock protein-based therapies to be used alone or in combination with current therapies for the eradication of triple-negative breast cancer. Recent studies on surface receptors and gene expression of breast tumors have come up with a term triple-negative breast cancer (TNBC), creating a phenotype and disease quite distinct from that seen in HER2- or ER-positive breast cancers, which is a much more aggressive disease without tumor-specific treatment options. Our studies employ gold nanoshell-mediated hyperthermia in combination with radiotherapy and chemotherapy, also known as the triple-modality approach. These studies received RGP Award from Scott & White Memorial Hospital.